North America Prescription Digital Therapeutics (PDTx) Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2020
  • North America
  • 350 Pages
  • No of Tables: 171
  • No of Figures: 61

North America Prescription Digital Therapeutics (PDTx) Market, By Mechanism (Input Mechanisms, Output Mechanisms), Category (Medication Augmentation, Medication Replacement), Treatment (Outpatient Treatment, Monotherapy), Software (Software For Respiratory Conditions, Software For Mental Health, Software For Opioid Use Disorder, Software For Diabetes, Others), Services (Behavioral Microservices, Medical Microservices), App Accessibility (Android, iOS, Windows), App Type (Native Apps, Web Apps), Application (Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others), Patients (Children, Adults), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2027

North America Prescription Digital Therapeutics (PDTx) MarketMarket Analysis and Insights : North America Prescription Digital Therapeutics (PDTx) Market

North America prescription digital therapeutics (PDTx) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 21.5% in the forecast period of 2020 to 2027 and is expected to reach USD 1,793.12 million by 2027 from USD 413.91 million in 2019. Rising prevalence of metabolic diseases such as diabetics and continuous monitoring of diseases at everywhere and extensive research & development activity in prescription digital therapeutics (PDTx) are the major drivers which propelled the demand of the market in the forecast period.

Prescription digital therapeutics has advanced the medical sciences and became a critical part of routine clinical care. The prescription digital therapeutics is used in order to treat medical and psychological condition using online software and services.

This digital therapeutics is either used as a standalone treatment solution or can be used in adjunction with the pharmacotherapy. The prescription digital therapeutics is in wide usage for treatment of metabolic conditions and mental health disorders among other chronic conditions. Prescription digital therapeutics can be delivered in a personalized manner and within a secure manner. These therapeutics applications and services provide with the cognitive behavioural therapy in order to manage the mental health problems and to treat substance use disorder or opioid use disorders. Prescription digital therapies have been proved to be more convenient and effective than the existing traditional medications as can be applied as per the patient schedule and location.

The demand for prescription digital therapeutics (PDTx) has been increased in both developed well as in developing countries and the reason behind this is increase in geriatric population rise in prevalence of chronic diseases. The prescription digital therapeutics (PDTx) market is growing due to high demand of cost effective digital therapeutics. The market will grow in the forecasted period with technological advancements and increasing funding activities.

The prescription digital therapeutics (PDTx) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Prescription Digital Therapeutics (PDTx) MarketNorth America Prescription Digital Therapeutics (PDTx) Market Scope and Market Size

Prescription digital therapeutics (PDTx) market is segmented on the based on the basis of mechanism, category, treatment, software, services, app accessibility, app type, application, patients. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of mechanism, North America prescription digital therapeutics (PDTx) market is segmented into input mechanisms and output mechanisms. In 2020, input mechanism segment is dominating the prescription digital therapeutics (PDTx) market as majority of prescription therapeutics devices are input based system.
  • On the basis of category, North America prescription digital therapeutics (PDTx) market is segmented into medication augmentation and medication replacement. In 2020, medication augmentation segment is dominating the prescription digital therapeutics (PDTx) market due to medication augmentation cannot replace the treatment by medication but it enhances the effectiveness of the treatment.
  • On the basis of treatment, North America prescription digital therapeutics (PDTx) market is segmented into outpatient treatment and monotherapy. In 2020, outpatient treatment segment is dominating the prescription digital therapeutics (PDTx) market due to prescription therapeutics majorly designed for the patients who cannot visit the doctor’s clinics regularly.
  • On the basis of software, North America prescription digital therapeutics (PDTx) market is segmented into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes and others. In 2020, software for diabetes segment is dominating the prescription digital therapeutics (PDTx) market as metabolic diseases are majorly affecting the North America population and a serious concern for the pharmaceutical industries.
  • On the basis of services, North America prescription digital therapeutics (PDTx) market is segmented into behavioral microservices and medical microservices. In 2020, behavioral microservices segment is dominating the prescription digital therapeutics (PDTx) market because prescription digital therapeutics majorly works on the patient’s behaviour as diseases it directly connected with the patients.
  • On the basis of app accessibility, North America prescription digital therapeutics (PDTx) market is segmented into android, iOS and windows. In 2020, androids segment is dominating the prescription digital therapeutics (PDTx) market because androids are the most commonly used or accessible software at every one can handle this and majority of application run via android software.
  • On the basis of app type, North America prescription digital therapeutics (PDTx) market is segmented into native app and web app. In 2020, native app segment is dominating the prescription digital therapeutics (PDTx) market because native app can be downloaded or purchased via the app store, these app cannot required any other software.
  • On the basis of application, North America prescription digital therapeutics (PDTx) market is segmented into substance use disorder (SUD), opioid use disorder (OUD), attention deficit/hyperactivity disorder (ADHD), alzheimer’s disease, major depressive disorder (MDD), insomnia, epilepsy, movement disorder, multiple sclerosis, migraine, autism spectrum disorder, oncology, inflammation, respiratory, cardiovascular, pain management, metabolic conditions, others. In 2020, metabolic conditions segment is dominating the prescription digital therapeutics (PDTx) market because diabetes is the most prevalent disease and required urgent technological devices for the monitoring.
  • On the basis of patients, North America prescription digital therapeutics (PDTx) market is segmented into children and adults. In 2020, adults segment is dominating the prescription digital therapeutics (PDTx) market because till now few prescriptions digital therapeutics supports the children data but all the applications supports the adults population data and can be used only for the adults.

 Prescription Digital Therapeutics (PDTx) Market Country Level Analysis

Prescription digital therapeutics (PDTx) market is analysed and market size information is provided by the basis of mechanism, category, treatment, software, services, app accessibility, app type, application and patients.

The countries covered in the prescription digital therapeutics (PDTx) market report are the U.S., Canada, and Mexico.

North America is expected to dominate the market due to the high adoption of prescription digital therapeutics (PDTx) by the patients in the region. The U.S is dominating in the market and leading the growth in the North America market due to increased presence of key market players in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increasing Acquisition and Merger in Prescription Digital Therapeutics (PDTx) Market is Creating New Opportunities for Players in the Prescription Digital Therapeutics (PDTx) Market

Prescription digital therapeutics (PDTx) market also provides you with detailed market analysis for every country growth in particular industry with Prescription digital therapeutics (PDTx) sales, impact of advancement in the prescription digital therapeutics (PDTx) and changes in regulatory scenarios with their support for the prescription digital therapeutics (PDTx) market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Prescription digital therapeutics (PDTx) Market Share Analysis

 Prescription digital therapeutics (PDTx) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to prescription digital therapeutics (PDTx) market.

The major companies which are dealing in the prescription digital therapeutics (PDTx) are Omada Health, Inc., ResMed, SAMSUNG, GAIA AG, Pear Therapeutics, Inc., Welldoc’s Bluestar, Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, BigHealth, Biofourmis, Click Therapeutics, Inc., Happify, Inc., Limbix Health, Inc., Naturalcycles, Nordic AB, NuvoAir AB, Sensyne Health plc., Voluntis, Xealth among others domestic and North America players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many products in pipeline and positive results by these clinical studies are also accelerating the prescription digital therapeutics (PDTx) market.

For instance,

  • In September 2020, Click Therapeutics, Inc. enters into collaboration with Boehringer Ingelheim to develop and commercialize CT-155 a novel prescription digital therapeutic for the treatment of Schizophrenia. With this, the company has enhanced its portfolio in the market.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the prescription digital therapeutics (PDTx) market which also provides the benefit for organisation to improve their offering for prescription digital therapeutics (PDTx) technology.

Customization Available: North America Prescription Digital Therapeutics (PDTx) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS

TABLE 3 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)

TABLE 4 NORTH AMERICA INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 5 NORTH AMERICA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 6 NORTH AMERICA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 7 NORTH AMERICA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 8 NORTH AMERICA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 9 NORTH AMERICAINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 10 NORTH AMERICA OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 11 NORTH AMERICA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 12 NORTH AMERICA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 14 NORTH AMERICA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 16 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)

TABLE 17 NORTH AMERICA MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 18 NORTH AMERICA MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)

TABLE 20 NORTH AMERICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 21 NORTH AMERICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 NORTH AMERICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)

TABLE 25 NORTH AMERICA SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 NORTH AMERICA SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 NORTH AMERICA SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 NORTH AMERICA SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 NORTH AMERICA OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)

TABLE 31 NORTH AMERICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 32 NORTH AMERICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 NORTH AMERICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)

TABLE 36 NORTH AMERICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 37 NORTH AMERICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 38 NORTH AMERICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 NORTH AMERICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 40 NORTH AMERICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 41 NORTH AMERICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 42 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)

TABLE 43 NORTH AMERICA NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 44 NORTH AMERICA WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 45 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)

TABLE 46 NORTH AMERICA METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 47 NORTH AMERICA MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 48 NORTH AMERICA RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 49 NORTH AMERICA CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 50 NORTH AMERICA SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 51 NORTH AMERICA OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 52 NORTH AMERICA INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 53 NORTH AMERICA PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 54 NORTH AMERICA ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 55 NORTH AMERICA MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 56 NORTH AMERICA INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 57 NORTH AMERICA ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 58 NORTH AMERICA MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 59 NORTH AMERICA ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 60 NORTH AMERICA EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 61 NORTH AMERICA MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 62 NORTH AMERICA AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 63 NORTH AMERICA OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)

TABLE 65 NORTH AMERICA ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 66 NORTH AMERICA CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 67 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 68 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 69 NORTH AMERICA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 70 NORTH AMERICA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 71 NORTH AMERICA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 72 NORTH AMERICA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 73 NORTH AMERICA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 74 NORTH AMERICA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 75 NORTH AMERICA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 76 NORTH AMERICA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 77 NORTH AMERICA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 78 NORTH AMERICA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 79 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 80 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 81 NORTH AMERICA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 82 NORTH AMERICA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 83 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 84 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 85 NORTH AMERICA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 86 NORTH AMERICA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 87 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 88 NORTH AMERICA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 89 NORTH AMERICA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 90 NORTH AMERICA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 91 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 92 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 93 NORTH AMERICA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 94 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 95 U.S. INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 96 U.S. PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 97 U.S. DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 98 U.S. AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 99 U.S. INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 100 U.S. OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 101 U.S. PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 102 U.S. ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 103 U.S. CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 104 U.S. OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 105 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 106 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 107 U.S. OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 108 U.S. MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 109 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 110 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 111 U.S. BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 112 U.S. MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 113 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 114 U.S. ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 115 U.S. IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 116 U.S. WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 117 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 118 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 119 U.S. PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 120 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 121 CANADA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 122 CANADA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 123 CANADA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 124 CANADA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 125 CANADA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 126 CANADA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 127 CANADA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 128 CANADA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 129 CANADA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 130 CANADA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 131 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 132 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 133 CANADA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 134 CANADA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 136 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 137 CANADA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 138 CANADA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 139 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 140 CANADA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 141 CANADA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 142 CANADA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 143 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 144 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 145 CANADA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 146 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 147 MEXCIO INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 148 MEXCIO PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 149 MEXCIO DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 150 MEXCIO AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 151 MEXCIO INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 152 MEXCIO OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 153 MEXCIO PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 154 MEXCIO ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 155 MEXCIO CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 156 MEXCIO OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 157 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 158 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 159 MEXCIO OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 160 MEXCIO MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 161 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 162 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 163 MEXCIO BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 164 MEXCIO MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 165 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 166 MEXCIO ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 167 MEXCIO IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 168 MEXCIO WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 169 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 170 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 171 MEXCIO PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions